About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

RECRUITINGPhase 4

Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)

NCT04861103•University of California, Irvine

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Pregnancy, High RiskAnticoagulants

Interventions

Lovenox

Locations

1

United States

Locations (1)

University of California Irvine

Orange, California, United States

Key Dates

Start Date

October 1, 2020

Primary Completion Date

December 31, 2026

Completion Date

July 31, 2027

Last Updated

October 29, 2025

Related Studies

RECRUITINGPhase 4

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

NCT06445946

Gestational Diabetes MellitusPregnancy, High Risk

Comparison of Heparin Anti-Xa Activity From Central Venous Catheter Samples Using a 5 mL Syringe Flush or a Vacuum Tube Flush Versus Peripheral Vein Samples in ICU Patients

NCT07183605

Anticoagulants and Bleeding Disorders

A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE

NCT05909046

Pre-Gestational DiabetesType2diabetes+4 more

Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring

NCT05739123

Pregnancy RelatedPregnancy Complications+1 more

Patients Pregnant Women With or Without Primary Antiphospholipid Antibody Syndrome

NCT05786235

PreeclampsiaImmunologic Disease+4 more

Prospective Observational Pilot Study of LMWH Versus UFH as ECMO Anticoagulation in Lung Transplantation

NCT06868823

Lung TransplantationExtracorporeal Membrane Oxygenation (ECMO)+1 more

View all related studies

Contacts

Lizette Spears

CONTACT

714.456.5694 lspiers@hs.uci.edu

Sponsors

Lead Sponsor

University of California, Irvine

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 29, 2025Data synced to Clareo: April 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions